search icon
News>GSK

GSK

Advertisement

Pharma giant GSK employee shouts racial slurs on flight, fired: WATCH video

GSK
GSK rejects $68 billion Unilever bid for consumer healthcare unit
GSK rejects $68 billion Unilever bid for consumer healthcare unit
GSK-CureVac's 2nd Covid vaccine shows better immune response
GSK-CureVac's 2nd Covid vaccine shows better immune response
DCGI gives nod for Sanofi-GSK's phase 3 trial of COVID vaccine in India
DCGI gives nod for Sanofi-GSK's phase 3 trial of COVID vaccine in India
Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial
Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial
Govt lifts restriction on export of Paracetamol, moves it to free category
Govt lifts restriction on export of Paracetamol, moves it to free category
GSK selling $3.45 billion stake in Hindustan Unilever
GSK selling $3.45 billion stake in Hindustan Unilever
GSK Consumers Healthcare gets shareholders' approval for merger with HUL
GSK Consumers Healthcare gets shareholders' approval for merger with HUL
GSK sells anaesthetics to Aspen for up to $370 million
GSK sells anaesthetics to Aspen for up to $370 million
GlaxoSmithKline, Alphabet create $715 million bioelectronics firm
GlaxoSmithKline, Alphabet create $715 million bioelectronics firm
GSK gets EU approval for first gene therapy for children
GSK gets EU approval for first gene therapy for children
GlaxoSmithKline CEO Witty to bow out in March 2017
GlaxoSmithKline CEO Witty to bow out in March 2017
Popular antidepressant neither safe nor effective for teens
Popular antidepressant neither safe nor effective for teens
GSK Pharma's Bengaluru facility to be operational by 2017
GSK Pharma's Bengaluru facility to be operational by 2017
GlaxoSmithKline targets growth across units, scraps ViiV listing
GlaxoSmithKline targets growth across units, scraps ViiV listing
New-look GSK bets on consumer health spending
New-look GSK bets on consumer health spending
Sun Pharma to buy GSK's opiates business in Australia
Sun Pharma to buy GSK's opiates business in Australia
EU puts conditions on deals involving Novartis, GSK
EU puts conditions on deals involving Novartis, GSK
Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr
Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr
GSK confirms hundreds of US job cuts as market gets tougher
GSK confirms hundreds of US job cuts as market gets tougher
Load More Stories